scispace - formally typeset
F

Franca Foppiano

Researcher at National Cancer Research Institute

Publications -  49
Citations -  26347

Franca Foppiano is an academic researcher from National Cancer Research Institute. The author has contributed to research in topics: Rectum & Dosimetry. The author has an hindex of 17, co-authored 47 publications receiving 22742 citations.

Papers
More filters
Journal ArticleDOI

Geant4—a simulation toolkit

S. Agostinelli, +126 more
TL;DR: The Gelfant 4 toolkit as discussed by the authors is a toolkit for simulating the passage of particles through matter, including a complete range of functionality including tracking, geometry, physics models and hits.
Journal ArticleDOI

Geant4 developments and applications

TL;DR: GeGeant4 as mentioned in this paper is a software toolkit for the simulation of the passage of particles through matter, it is used by a large number of experiments and projects in a variety of application domains, including high energy physics, astrophysics and space science, medical physics and radiation protection.
Journal ArticleDOI

Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).

TL;DR: Different NTCP models fit quite accurately the considered clinical data and are consistent with a rectum 'less serial' than previously reported investigations when considering grade 2 bleeding while a more serial behaviour was found for severe bleeding.
Journal ArticleDOI

Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions

TL;DR: The role of the rectal DVH in separating groups of patients having prostate radiotherapy in low and high risk of developing late bleeding is confirmed, and the association of adjuvant hormone deprivation seems to be associated with an increased risk of rectal toxicity.
Journal ArticleDOI

Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer.

TL;DR: Evidence is provided for correlation between rectal DVH parameters and late rectal bleeding in patients treated with curative intent with 3D-CRT and it seems advisable to limit V(50) to 60-65%, V(60) to 45-50%, and V70 to 25-30%.